Richard Wolf Medical Instruments Corp

Richard Wolf Medical Instruments Corp, a foreign-owned manufacturer of surgical and endoscopic medical devices based in Vernon Hills, Illinois, operates as a prime contractor delivering urological, laparoscopic, and diagnostic equipment to federal healthcare agencies on a full-and-open basis with no set-aside designations. The company holds a GSA Schedule 65-II-A contract for Medical Equipment and Supplies, under which the vast majority of its federal work flows, and competes exclusively through general competition rather than small-business set-asides.

Richard Wolf's federal footprint concentrates in the VA system. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 anchors the portfolio with 107 awards valued at $24 million in combined potential value, representing roughly 52% of the company's total federal potential value across all customers. The Department of the Army Medical Command ranks second with 68 awards totaling $4.8 million, followed by the Department of the Navy Bureau of Medicine and Surgery with 154 awards totaling $3.2 million. The top five customers by potential value—VISN 12, Army Medical Command, Navy Bureau of Medicine and Surgery, Indian Health Service, and Defense Health Agency—account for 77% of combined potential value. The concentration by award count differs from the dollars ranking: Navy BUMED leads in transaction volume (154 orders) but carries much lower per-order values than VISN 12's larger individual delivery orders.

Richard Wolf's concrete capability footprint centers on specialized surgical and diagnostic instrumentation. The company supplies morcellation systems (Piranha brand), resectoscopes, cystoscopes, ureteroscopes, laser enucleation devices, laparoscopic equipment, hysteroscopes, nephroscopes, and endoscopy trays. Recent representative work includes a $1.45 million Defense Health Agency delivery order (awarded June 2022) for endoscopy equipment maintenance at Fort Stewart, Georgia, running through June 2027; a $287.97 thousand Indian Health Service order (September 2023) for laparoscopic equipment purchase; and a $236.30 thousand Veterans Integrated Service Network 6 delivery order (March 2025) for a digital camera controller bundle with sensors. The company also provides preventative maintenance services, repair services, and equipment supply on an as-needed basis. All recent awards cited in the source are firm fixed-price delivery orders under the GSA Medical Equipment and Supplies Schedule with no subcontractors identified.

Richard Wolf operates entirely through the GSA Medical Equipment and Supplies Schedule 65-II-A vehicle, which carries 542 task orders valued at $18.8 million in combined potential value. Secondary vehicles appear at much lower volume: Federal Supply Schedules V797P4127A (23 task orders, $68 thousand) and V797P3286K (4 task orders) and a handful of indefinite delivery contracts carry minimal additional activity. The company's award portfolio spans 1,154 prime awards across 42 distinct customer agencies since 1981, with recent activity averaging 9 awards per year over the past five years. The portfolio shows moderate volatility—13 awards in 2022, declining to 5 in 2024, then recovering to 10 in 2026—but remains focused on high-volume, lower-dollar-per-order transactional work typical of GSA Schedule medical device supply.

Recompete exposure in the next twenty-four months is minimal: only seven awards with ultimate completion dates in that window carry combined potential value of $1.9 million. The company has demonstrated sustained federal healthcare supplier status since 2001, with its primary NAICS profile split between Surgical and Medical Instrument Manufacturing (682 awards) and Other Electronic and Precision Equipment Repair and Maintenance (54 awards), and its PSC profile weighted toward Medical and Surgical Instruments, Equipment, and Supplies (858 awards) and maintenance/repair services (160 awards). Richard Wolf does not sub-award; all 1,154 awards carry prime responsibility. The vendor competes on commercial terms without small-business designation, relying on brand-name product leadership and established GSA Schedule positioning to sustain its federal healthcare customer relationships.